| 000 | 01536 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513052502.0 | ||
| 264 | 0 | _c19941221 | |
| 008 | 199412s 0 0 eng d | ||
| 022 | _a0284-186X | ||
| 024 | 7 |
_a10.3109/02841869409121775 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPiguet, D | |
| 245 | 0 | 0 |
_aRecombinant human granulocyte-macrophage colony-stimulating factor in acquired or chemotherapy-induced neutropenia. An open clinical trial. _h[electronic resource] |
| 260 |
_bActa oncologica (Stockholm, Sweden) _c1994 |
||
| 300 |
_a639-43 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xcomplications |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBone Marrow Transplantation _xadverse effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukocyte Count _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 |
_aNeutropenia _xchemically induced |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 700 | 1 | _aChapuis, B | |
| 773 | 0 |
_tActa oncologica (Stockholm, Sweden) _gvol. 33 _gno. 6 _gp. 639-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/02841869409121775 _zAvailable from publisher's website |
| 999 |
_c7945770 _d7945770 |
||